title: Development and characterization of pilocarpine loaded Eudragit nanosuspensions for ocular drug delivery.
abstract: With aim of improving the availability of drug at intraocular level and to reduce the frequency of drug administration, pilocarpine nitrate nanosuspensions were made from inert polymer resin (Eudragit RL 100) with varying drug to polymer ratios using Lutrol F68 solution in various concentration. Nanosuspensions were successfully prepared by solvent displacement method. Size of nanoparticles varied between 121.5 +/- 2.28 to 291.5 +/- 1.28 nm, a polydispersity index ranging from 0.218 +/- 0.003 to 0.658 +/- 0.035 with zeta potential ranging +14.1 +/- 0.7 to +19.8 +/- 2.3 mV. Differential scanning calorimetry (DSC) and Fourier transform infrared spectroscopy (FTIR) studies clearly suggest the compatibility of the drug with the polymer used. Scanning electron microscopy (SEM) and Transmission electron microscopy (TEM) studies completely revealed that the drug loaded nanoparticles were found to be distinct, spherical in shape having a smooth surface and the drug is molecularly dispersed uniformly throughout the whole polymer matrix. PRL4 was successfully able to sustain the drug release for 24 hr as compared to other batches of formulated nanosuspensions. No significant change in average particle size and zeta potential were observed after conducting stability studies. Results of the studies clearly suggest the suitability of Eudragit RL 100 as a promising potential drug delivery adjuvant for ocular drug administration.
authors.affiliation: Department of Pharmaceutics, JSS College of Pharmacy, JSS University, Sri Shivarathreeshwara Nagara, Mysore 570015, India.
authors.forename: Mohammed S
authors.initials: MS
authors.lastname: Khan
authors.forename: Gowda D
authors.initials: GD
authors.lastname: Vishakante
authors.forename: Afifa
authors.initials: A
authors.lastname: Bathool
mesh_terms: D000818:Animals; D002152:Calorimetry, Differential Scanning; D016503:Drug Delivery Systems; D004355:Drug Stability; D005123:Eye / Q000187:drug effects*; D008938:Mitosis / Q000187:drug effects; D053758:Nanoparticles / Q000737:chemistry* / Q000648:ultrastructure; D010316:Particle Size; D010862:Pilocarpine / Q000008:administration & dosage* / Q000494:pharmacology*; D011109:Polymethacrylic Acids / Q000737:chemistry*; D011817:Rabbits; D017550:Spectroscopy, Fourier Transform Infrared; D055672:Static Electricity; D013535:Suspensions
chemical_list: D011109:Polymethacrylic Acids; D013535:Suspensions; D010862:Pilocarpine; C038300:methylmethacrylate-methacrylic acid copolymer